首页> 外国专利> STABLE PHARMACEUTICAL COMPOSITION OF 3- (HYDROXIMETIL) -5,5-DIPHENYL HYDANTOINE PHOSPHATE ESTER.

STABLE PHARMACEUTICAL COMPOSITION OF 3- (HYDROXIMETIL) -5,5-DIPHENYL HYDANTOINE PHOSPHATE ESTER.

机译:3-(羟基)-5,5-二苯乙醛磷酸酯的稳定药物组成。

摘要

A STABLE PHARMACEUTICAL COMPOSITION OF ESTER 3- (HYDROXYMETHYL) -5, 5-DIPHENYLHIDANTONINE DISODIC PHOSPHATE, PRO MEDICATION OF 5, 5-DIPHENYL HYDANTONINE (PHENITOIN), A COMMONLY USED TREATMENT AND TREATMENT, IS DESCRIBED CONVULSIVE STATES. IT IS KNOWN THAT THE DEGRADATION OF PENTINA PRODROGUE CAN BE CONTROLLED BY CONTROLLING THE PH OF THE COMPOSITION. CONTROLLING THE PH BETWEEN 8.3 AND 9.4 OF A RESULT OF A PRODUCTION OF DIPHENYLGLYCINAMIDE AS THE PRIMARY DEGRADANT AND MINIMIZATION OF DEGRADATION TO FENTONIA. IF THE PH IS MAINTAINED IN A LOWER OR HIGHER VALUE, THEN THE PATTERN OF DEGRADATION CHANGES, WITH A FAILURE OF THE PRODUCT EARLIER THAN EXPECTED.
机译:描述了一种令人困惑的治疗状态,即酯3-(羟甲基)-5,5-二苯己基二氢磷酸二酯的稳定药物组成,5,5-二苯二氢他汀(苯妥英)的药物治疗。众所周知,可以通过控制组合物的pH值来控制戊糖原的降解。控制作为主要降解剂的二苯乙酰胺的生产结果和最小化降解为Fentonia的结果的8.3和9.4之间的pH值。如果将PH保持在较低或较高的值,则会发生降解变化的模式,从而导致产品过早损坏。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号